A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma
Clinical trial NCT04837222 · COMPLETED
Trial details
- NCT number
- NCT04837222
- Sponsor
- Takeda
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-07
- Primary completion
- 2026-06-26
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.